Tips for Sharing and Spreading Awareness Online

Tips for Sharing and Spreading Awareness Online

Our PSP✔️ team is dedicated to ensuring that relevant and consistent information is available to all, especially for rare diseases like PSP.

In today's world, information is readily available at our fingertips. With the rise of social media and the internet, it's easier than ever to share information with others. However, it's important to remember that not all information is accurate or up to date.

This is especially true when it comes to PSP (Progressive Supranuclear Palsy) information. PSP is a rare neurological disorder that affects movement, balance, and vision. As research continues, new information is constantly being discovered about the disease.

It's crucial to verify any information you plan to share about PSP to ensure that it's the most up to date and relevant. Sharing outdated or inaccurate information can lead to confusion and misinformation, which can be harmful to those affected by the disease.

By taking the time to verify information before sharing it, you can help ensure that accurate and helpful information is being spread. This can lead to a better understanding of PSP and ultimately, better care and treatment for those affected by the disease.

One way to verify information is to check the source. Make sure the information is coming from a reputable source, such as a medical journal or a trusted and active organization like CurePSP, PSP Association and CCF for PSP Awareness. Even from trusted sources it is still crucial to verify that the information is up to date and accurate before sharing. You can also consult with medical professionals or support groups to get the most accurate information.

In addition, it's important to keep in mind that PSP is a complex disease and can present differently in each individual. What may be true for one person may not be true for another. Therefore, it's important to approach information with an open mind and be willing to learn and adapt as new information becomes available.

In conclusion, verifying information before sharing it is crucial, especially when it comes to PSP. By doing so, we can help ensure that accurate and up-to-date information is being shared, which can have a positive impact on those affected by the disease and the medical community working to find a cure.

All services and alerts are provided by PSP✔️ team at no cost and on behalf of CCF for PSP Awareness. Please do not hesitate to inform us of any urgent misinformation or new information that needs to be updated worldwide about PSP, MSA, CBD, ALS, DLB and Parkinsons.

Thank you for your dedication to spreading awareness!

The PSP✔️ Team
Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • 🥯 Bagel Fundraiser

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment
  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

1 of 4